The MedTech arena is not the easiest to navigate with how many companies are in it. It's all about finding emerging players like BSEM who have successfully navigated the regulatory process (a real barrier to entry) and show real growth!The MedTech sector is often overlooked but is just as innovative as many of the top tech names. Two massive multi-billion-dollar markets for its regenerative therapies position BioStem Technologies Inc. (OTC: BSEM) as one of the most promising up-and-coming MedTech stocks on Wall Street! 2023 was a pivotal year for BSEM which has established a solid foundation for the company's future expansion, which now includes a potential uplisting to a senior stock exchange! The company also recently released its 1Q2024 earnings results, which vastly exceeded estimates as revenue growth accelerated, and the company posted its FIRST quarterly profit. These stellar results have led to Zack's Small Cap Research increasing its price target to $23.25! "We reiterate our belief the BSEM is still underpriced even after its recent move higher and continues to represent a good opportunity at recent prices for investors to get in before what we believe will be a more aggressive move higher in the not-too-distant future," says Zack's. BioStem Technologies, Inc. (OTCQB: BSEM) is making waves for its focus on harnessing elements of perinatal tissue derived from the human placenta for manufacturing structural tissue allografts to heal wounds. The market for improved wound care products is growing exponentially. In terms of revenue, the global wound care market in terms of revenue was estimated to be worth $20.8 billion in 2022 and is poised to reach $27.2 billion by 2027, growing at a CAGR of 5.4% from 2022 to 2027. The company remains committed to its mission of delivering unparalleled wound care solutions for patients and healthcare professionals, and look forward to broadening its reach into new markets this year. SEE WHY BIOSTEM TECHNOLOGIES INC.: A HIDDEN GEM IN THE GROWING MEDTECH SPACE THAT NOW CARRIES A $23.25 ZACKS PRICE TARGET!This message is a PAID ADVERTISEMENT for BioStem Technologies, Inc. (BSEM) from Sideways Frequency. StockEarnings, Inc receives a fixed fee of $2000 for two Dedicated Email Sends. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either BioStem Technologies, Inc. (BSEM) or Sideways Frequency. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding BioStem Technologies, Inc. (BSEM) on Huge Alerts website for additional information about the relationship between Sideways Frequency and BioStem Technologies, Inc. (BSEM). Your privacy is very important to us, if you wish to be excluded from future notices, do not reply to this message. Instead, please click Unsubscribe. StockEarnings, Inc |
Tidak ada komentar:
Posting Komentar